- Home
- BTM vs NYXH Comparison
BTM vs NYXH Comparison
Compare BTM & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTM
- NYXH
- Stock Information
- Founded
- BTM 2016
- NYXH 2009
- Country
- BTM United States
- NYXH Belgium
- Employees
- BTM N/A
- NYXH N/A
- Industry
- BTM Finance: Consumer Services
- NYXH Medical/Dental Instruments
- Sector
- BTM Finance
- NYXH Health Care
- Exchange
- BTM Nasdaq
- NYXH Nasdaq
- Market Cap
- BTM 267.6M
- NYXH 231.0M
- IPO Year
- BTM N/A
- NYXH 2021
- Fundamental
- Price
- BTM $3.93
- NYXH $5.24
- Analyst Decision
- BTM Strong Buy
- NYXH Strong Buy
- Analyst Count
- BTM 2
- NYXH 3
- Target Price
- BTM $6.00
- NYXH $15.00
- AVG Volume (30 Days)
- BTM 872.7K
- NYXH 83.6K
- Earning Date
- BTM 11-12-2025
- NYXH 11-05-2025
- Dividend Yield
- BTM N/A
- NYXH N/A
- EPS Growth
- BTM N/A
- NYXH N/A
- EPS
- BTM 0.12
- NYXH N/A
- Revenue
- BTM $608,432,000.00
- NYXH $5,793,306.00
- Revenue This Year
- BTM $9.78
- NYXH $118.20
- Revenue Next Year
- BTM $6.95
- NYXH $278.04
- P/E Ratio
- BTM $32.41
- NYXH N/A
- Revenue Growth
- BTM N/A
- NYXH 2.94
- 52 Week Low
- BTM $0.93
- NYXH $5.24
- 52 Week High
- BTM $6.88
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- BTM 46.96
- NYXH 27.77
- Support Level
- BTM $3.36
- NYXH $5.45
- Resistance Level
- BTM $3.96
- NYXH $6.09
- Average True Range (ATR)
- BTM 0.19
- NYXH 0.26
- MACD
- BTM 0.07
- NYXH -0.04
- Stochastic Oscillator
- BTM 95.00
- NYXH 0.00
About BTM Bitcoin Depot Inc.
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.